🎉 M&A multiples are live!
Check it out!

Imeik Technology Development Valuation Multiples

Discover revenue and EBITDA valuation multiples for Imeik Technology Development and similar public comparables like Armata Pharmaceuticals, Julphar, and Vivoryon Therapeutics.

Imeik Technology Development Overview

About Imeik Technology Development

Imeik Technology Development Co Ltd is engaged in Research and development, production and sales of biomedical materials and biopharmaceuticals.


Founded

2004

HQ

China
Employees

n/a

Website

imeik.net

Financials

LTM Revenue $434M

LTM EBITDA $324M

EV

$7.1B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Imeik Technology Development Financials

Imeik Technology Development has a last 12-month revenue of $434M and a last 12-month EBITDA of $324M.

In the most recent fiscal year, Imeik Technology Development achieved revenue of $417M and an EBITDA of $321M.

Imeik Technology Development expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Imeik Technology Development valuation multiples based on analyst estimates

Imeik Technology Development P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $395M $417M XXX XXX XXX
Gross Profit $253M $376M XXX XXX XXX
Gross Margin 64% 90% XXX XXX XXX
EBITDA $303M $321M XXX XXX XXX
EBITDA Margin 77% 77% XXX XXX XXX
Net Profit $174M $256M XXX XXX XXX
Net Margin 44% 61% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Imeik Technology Development Stock Performance

As of April 15, 2025, Imeik Technology Development's stock price is CNY 184 (or $25).

Imeik Technology Development has current market cap of CNY 55.6B (or $7.7B), and EV of CNY 51.3B (or $7.1B).

See Imeik Technology Development trading valuation data

Imeik Technology Development Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$7.1B $7.7B XXX XXX XXX XXX $0.94

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Imeik Technology Development Valuation Multiples

As of April 15, 2025, Imeik Technology Development has market cap of $7.7B and EV of $7.1B.

Imeik Technology Development's trades at 16.3x LTM EV/Revenue multiple, and 21.8x LTM EBITDA.

Analysts estimate Imeik Technology Development's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Imeik Technology Development and 10K+ public comps

Imeik Technology Development Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $7.1B XXX XXX XXX
EV/Revenue 16.9x XXX XXX XXX
EV/EBITDA 22.0x XXX XXX XXX
P/E 28.4x XXX XXX XXX
P/E/Growth 2.1x XXX XXX XXX
EV/FCF 30.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Imeik Technology Development Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Imeik Technology Development Valuation Multiples

Imeik Technology Development's NTM/LTM revenue growth is 13%

Imeik Technology Development's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Imeik Technology Development's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Imeik Technology Development's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Imeik Technology Development and other 10K+ public comps

Imeik Technology Development Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 5% XXX XXX XXX XXX
EBITDA Margin 77% XXX XXX XXX XXX
EBITDA Growth 6% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 90% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 3% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 10% XXX XXX XXX XXX
Opex to Revenue 23% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Imeik Technology Development Public Comps

See public comps and valuation multiples for Biopharmaceuticals comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Imeik Technology Development M&A and Investment Activity

Imeik Technology Development acquired  XXX companies to date.

Last acquisition by Imeik Technology Development was  XXXXXXXX, XXXXX XXXXX XXXXXX . Imeik Technology Development acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Imeik Technology Development

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Imeik Technology Development

When was Imeik Technology Development founded? Imeik Technology Development was founded in 2004.
Where is Imeik Technology Development headquartered? Imeik Technology Development is headquartered in China.
Is Imeik Technology Development publicy listed? Yes, Imeik Technology Development is a public company listed on SHE.
What is the stock symbol of Imeik Technology Development? Imeik Technology Development trades under 300896 ticker.
When did Imeik Technology Development go public? Imeik Technology Development went public in 2020.
Who are competitors of Imeik Technology Development? Similar companies to Imeik Technology Development include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Imeik Technology Development? Imeik Technology Development's current market cap is $7.7B
What is the current revenue of Imeik Technology Development? Imeik Technology Development's last 12-month revenue is $434M.
What is the current EBITDA of Imeik Technology Development? Imeik Technology Development's last 12-month EBITDA is $324M.
What is the current EV/Revenue multiple of Imeik Technology Development? Current revenue multiple of Imeik Technology Development is 16.3x.
What is the current EV/EBITDA multiple of Imeik Technology Development? Current EBITDA multiple of Imeik Technology Development is 21.8x.
What is the current revenue growth of Imeik Technology Development? Imeik Technology Development revenue growth between 2023 and 2024 was 5%.
Is Imeik Technology Development profitable? Yes, Imeik Technology Development is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.